Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The RAVI Registry: A Prospective, Multi-Center, Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres

NCT04272216 is registered in ClinicalTrials.gov with Terumo Medical Corporation as lead sponsor.

NCT NCT04272216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04272216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The RAVI Registry: A Prospective, Multi-Center, Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres
Lead sponsor
Terumo Medical Corporation
Phase
Observational
Overall status
Completed
Start date
February 6, 2020
Completion date
March 11, 2023
Enrollment
99 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

arteriovenous malformations, benign prostatic hyperplasia, hypervascular tumors, uterine fibroid